"Sclerosing Solutions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical agents injected into blood vessels and lymphatic sinuses to shrink or cause localized THROMBOSIS; FIBROSIS, and obliteration of the vessels. This treatment is applied in a number of conditions such as VARICOSE VEINS; HEMORRHOIDS; GASTRIC VARICES; ESOPHAGEAL VARICES; PEPTIC ULCER HEMORRHAGE.
| Descriptor ID |
D012597
|
| MeSH Number(s) |
D26.776.708.822 D27.505.954.411.700 D27.505.954.578.822 D27.720.752.822
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sclerosing Solutions".
Below are MeSH descriptors whose meaning is more specific than "Sclerosing Solutions".
This graph shows the total number of publications written about "Sclerosing Solutions" by people in this website by year, and whether "Sclerosing Solutions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sclerosing Solutions" by people in Profiles.
-
Management of cervicofacial lymphatic malformations requires a multidisciplinary approach. J Pediatr Surg. 2021 May; 56(5):1062-1067.
-
Management of a case of orbital lymphangioma presenting in adulthood with negative-pressure aspiration and bleomycin injection. BMJ Case Rep. 2019 Jun 08; 12(6).
-
OK432 versus doxycycline for treatment of macrocystic lymphatic malformations. Ann Otol Rhinol Laryngol. 2014 Feb; 123(2):81-8.
-
Doxycycline sclerotherapy as the primary treatment for head and neck lymphatic malformations. Otolaryngol Head Neck Surg. 2007 Dec; 137(6):962-4.
-
An injectable tissue-engineered embolus prevents luminal recanalization after vascular sclerotherapy. J Pediatr Surg. 2005 Jun; 40(6):920-5.
-
[A new treatment of osteoid osteoma: percutaneous sclerosis with ethanol under scanner guidance]. J Radiol. 1996 Jan; 77(1):37-40.
-
Development of large spleno-adreno-renal shunt after endoscopic sclerotherapy. Gastroenterology. 1989 Aug; 97(2):421-6.
-
Sclerotherapy-associated esophageal ulcers: lessons from a double-blind, randomized comparison of sucralfate suspension versus placebo. Gastrointest Endosc. 1989 Jul-Aug; 35(4):312-5.
-
Continuous thoracic epidural analgesia for the control of pain associated with pleural sclerosis. Gynecol Oncol. 1989 Jan; 32(1):76-8.
-
Ostomy closure for recurrent stomal hemorrhage: an indication for prophylactic sclerotherapy in biliary atresia. J Pediatr Surg. 1988 Jul; 23(7):630-1.